CoChat

Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP

Open access
Hu, Qi, Shokat, Kevan M. · 2018 · Cell
Cited by 65

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary The single most frequent cancer-causing mutation across all heterotrimeric G proteins is R201C in Gαs. The current model explaining the gain-of-function activity of the R201 mutations is through the loss of GTPase activity and resulting inability to switch off to the GDP state. Here, we find that the R201C mutation can bypass the need for GTP binding by directly activating GDP-bound Gαs through stabilization of an intramolecular hydrogen bond network. Having found that a gain-of-function mutation can convert GDP into an activator, we postulated that a reciprocal mutation might disrupt the normal role of GTP. Indeed, we found R228C, a loss-of-function mutation in Gαs that causes pseudohypoparathyroidism type 1a (PHP-Ia), compromised the adenylyl cyclase-activating activity of Gαs bound to a non-hydrolyzable GTP analog. These findings show that disease-causing mutations in Gαs can subvert the canonical roles of GDP and GTP, providing new insights into the regulation mechanism of G proteins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2018.03.018

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 45

  1. Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  2. Battye, 2011, iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM, Acta Crystallogr. D Biol. Crystallogr., 67, 271, 10.1107/S0907444910048675 · DOI · Paper page
  3. Biasini, 2014, SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information, Nucleic Acids Res., 42, 10.1093/nar/gku340 · DOI · Paper page
  4. Bourne, 1997, G proteins. The arginine finger strikes again, Nature, 389, 673, 10.1038/39470 · DOI
  5. Brandt, 1985, GTPase activity of the stimulatory GTP-binding regulatory protein of adenylate cyclase, Gs. Accumulation and turnover of enzyme-nucleotide intermediates, J. Biol. Chem., 260, 266, 10.1016/S0021-9258(18)89726-5 · DOI
  6. Brandt, 1986, Catecholamine-stimulated GTPase cycle. Multiple sites of regulation by beta-adrenergic receptor and Mg2+ studied in reconstituted receptor-Gs vesicles, J. Biol. Chem., 261, 1656, 10.1016/S0021-9258(17)35991-4 · DOI · Paper page
  7. Coleman, 1998, Crystal structures of the G protein Gi alpha 1 complexed with GDP and Mg2+: a crystallographic titration experiment, Biochemistry, 37, 14376, 10.1021/bi9810306 · DOI
  8. De Haan, 2004, Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review), Mol. Membr. Biol., 21, 77, 10.1080/09687680410001663267 · DOI · Paper page
  9. Emsley, 2010, Features and development of Coot, Acta Crystallogr. D Biol. Crystallogr., 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
  10. Evans, 2006, Scaling and assessment of data quality, Acta Crystallogr. D Biol. Crystallogr., 62, 72, 10.1107/S0907444905036693 · DOI · Paper page
  11. Flock, 2015, Universal allosteric mechanism for Gα activation by GPCRs, Nature, 524, 173, 10.1038/nature14663 · DOI · Paper page
  12. Gilman, 1987, G proteins: transducers of receptor-generated signals, Annu. Rev. Biochem., 56, 615, 10.1146/annurev.bi.56.070187.003151 · DOI · Paper page
  13. Gilman, 1995, G Proteins and regulation of adenylate cyclase (Nobel lecture), Angew. Chem. Int. Ed. Engl., 34, 1406, 10.1002/anie.199514061 · DOI
  14. Goricanec, 2016, Conformational dynamics of a G-protein α subunit is tightly regulated by nucleotide binding, Proc. Natl. Acad. Sci. USA, 113, E3629, 10.1073/pnas.1604125113 · DOI · Paper page
  15. Gout, 2014, Interplay of Mg2+, ADP, and ATP in the cytosol and mitochondria: unravelling the role of Mg2+ in cell respiration, Proc. Natl. Acad. Sci. USA, 111, E4560, 10.1073/pnas.1406251111 · DOI · Paper page
  16. Hanoune, 2001, Regulation and role of adenylyl cyclase isoforms, Annu. Rev. Pharmacol. Toxicol., 41, 145, 10.1146/annurev.pharmtox.41.1.145 · DOI · Paper page
  17. Higashijima, 1987, The effect of GTP and Mg2+ on the GTPase activity and the fluorescent properties of Go, J. Biol. Chem., 262, 757, 10.1016/S0021-9258(19)75850-5 · DOI · Paper page
  18. Higashijima, 1987, The effect of activating ligands on the intrinsic fluorescence of guanine nucleotide-binding regulatory proteins, J. Biol. Chem., 262, 752, 10.1016/S0021-9258(19)75849-9 · DOI · Paper page
  19. Higashijima, 1987, Effects of Mg2+ and the beta gamma-subunit complex on the interactions of guanine nucleotides with G proteins, J. Biol. Chem., 262, 762, 10.1016/S0021-9258(19)75851-7 · DOI · Paper page
  20. Iiri, 1997, Conditional activation defect of a human Gsalpha mutant, Proc. Natl. Acad. Sci. USA, 94, 5656, 10.1073/pnas.94.11.5656 · doi:10.1073/pnas.94.11.5656
  21. Kahn, 1984, ADP-ribosylation of Gs promotes the dissociation of its alpha and beta subunits, J. Biol. Chem., 259, 6235, 10.1016/S0021-9258(20)82131-0 · doi:10.1016/s0021-9258(20)82131-0
  22. Khan, 2013, The expanding roles of Gβγ subunits in G protein-coupled receptor signaling and drug action, Pharmacol. Rev., 65, 545, 10.1124/pr.111.005603 · DOI · Paper page
  23. Lambright, 1994, Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein, Nature, 369, 621, 10.1038/369621a0 · DOI · Paper page
  24. Landis, 1989, GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours, Nature, 340, 692, 10.1038/340692a0 · DOI · Paper page
  25. Le, 2013, Site-specific and regiospecific installation of methylarginine analogues into recombinant histones and insights into effector protein binding, J. Am. Chem. Soc., 135, 2879, 10.1021/ja3108214 · DOI
  26. Lemos, 2015, GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders, Hum. Mutat., 36, 11, 10.1002/humu.22696 · DOI
  27. Leyme, 2014, Different biochemical properties explain why two equivalent Gα subunit mutants cause unrelated diseases, J. Biol. Chem., 289, 21818, 10.1074/jbc.M114.549790 · DOI
  28. McCoy, 2007, Phaser crystallographic software, J. Appl. Cryst., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
  29. Mixon, 1995, Tertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysis, Science, 270, 954, 10.1126/science.270.5238.954 · DOI · Paper page
  30. Muntz, 1992, Influence of gamma subunit prenylation on association of guanine nucleotide-binding regulatory proteins with membranes, Mol. Biol. Cell, 3, 49, 10.1091/mbc.3.1.49 · DOI
  31. Nishimura, 2010, Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule, Proc. Natl. Acad. Sci. USA, 107, 13666, 10.1073/pnas.1003553107 · DOI · Paper page
  32. O’Hayre, 2013, The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer, Nat. Rev. Cancer, 13, 412, 10.1038/nrc3521 · DOI · Paper page
  33. Phillips, 1988, The intrinsic fluorescence of the alpha subunit of transducin. Measurement of receptor-dependent guanine nucleotide exchange, J. Biol. Chem., 263, 15498, 10.1016/S0021-9258(19)37616-1 · DOI
  34. Rodenhuis, 1987, Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung, N. Engl. J. Med., 317, 929, 10.1056/NEJM198710083171504 · DOI · Paper page
  35. Romani, 2011, Cellular magnesium homeostasis, Arch. Biochem. Biophys., 512, 1, 10.1016/j.abb.2011.05.010 · DOI · Paper page
  36. Sprang, 2016, Invited review: activation of G proteins by GTP and the mechanism of Gα-catalyzed GTP hydrolysis, Biopolymers, 105, 449, 10.1002/bip.22836 · DOI
  37. Sunahara, 1997, Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase, J. Biol. Chem., 272, 22265, 10.1074/jbc.272.35.22265 · DOI · Paper page
  38. Sunahara, 1997, Crystal structure of the adenylyl cyclase activator Gsalpha, Science, 278, 1943, 10.1126/science.278.5345.1943 · DOI · Paper page
  39. Tam, 2014, A novel mutation in pseudohypoparathyroidism type 1a in a Chinese woman and her son with hypocalcaemia, Hong Kong Med. J., 20, 258, 10.12809/hkmj134025 · DOI
  40. Vallar, 1987, Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas, Nature, 330, 566, 10.1038/330566a0 · DOI · Paper page
  41. Wall, 1995, The structure of the G protein heterotrimer Gi α 1 β 1 γ 2, Cell, 83, 1047, 10.1016/0092-8674(95)90220-1 · DOI · Paper page
  42. Warner, 1999, A mutation in the heterotrimeric stimulatory guanine nucleotide binding protein alpha-subunit with impaired receptor-mediated activation because of elevated GTPase activity, Proc. Natl. Acad. Sci. USA, 96, 4268, 10.1073/pnas.96.8.4268 · DOI
  43. Warner, 1998, A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation, J. Biol. Chem., 273, 23976, 10.1074/jbc.273.37.23976 · DOI
  44. Winn, 2011, Overview of the CCP4 suite and current developments, Acta Crystallogr. D Biol. Crystallogr., 67, 235, 10.1107/S0907444910045749 · DOI · Paper page
  45. Zuev, 2004, Singlet vinylcarbenes: spectroscopy and photochemistry, J. Am. Chem. Soc., 126, 12220, 10.1021/ja046309q · doi:10.1021/ja046309q

Cited by

See all 65

Metadata

Authors
Hu, Q., & Shokat, K. M.
Venue
Cell
Publisher
Elsevier BV
Published
2018-05
Volume
173
Issue
5
Pages
1254-1264.e11
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2796302334
Cited by
65
References
5
FWCI
1.26
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Howard Hughes Medical Institute
  • National Institutes of Health (R01CA190408)
  • Samuel Waxman Cancer Research Foundation
  • Damon Runyon Cancer Research Foundation (DRG-[2229-15)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.